U.S. Large Molecule Drug Discovery Outsourcing Market Size & Outlook
Related Markets
U.S. large molecule drug discovery outsourcing market highlights
- The U.S. large molecule drug discovery outsourcing market generated a revenue of USD 968.6 million in 2024 and is expected to reach USD 1,589.7 million by 2030.
- The U.S. market is expected to grow at a CAGR of 8.7% from 2025 to 2030.
- In terms of segment, lead identification & candidate optimization was the largest revenue generating workflow in 2024.
- Other Associated Workflow is the most lucrative workflow segment registering the fastest growth during the forecast period.
Large molecule drug discovery outsourcing market data book summary
| Market revenue in 2024 | USD 968.6 million |
| Market revenue in 2030 | USD 1,589.7 million |
| Growth rate | 8.7% (CAGR from 2025 to 2030) |
| Largest segment | Lead identification & candidate optimization |
| Fastest growing segment | Other Associated Workflow |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Target Identification & Screening, Target Validation & Functional Informatics, Lead Identification & Candidate Optimization, Preclinical Development, Other Associated Workflow |
Other key industry trends
- In terms of revenue, U.S. accounted for 33.5% of the global large molecule drug discovery outsourcing market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. large molecule drug discovery outsourcing market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 282.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Large Molecule Drug Discovery Outsourcing Market Scope
Large Molecule Drug Discovery Outsourcing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Laboratory Corporation of America Holdings | View profile | - | - | - |
| WuXi AppTec | View profile | - | - | - |
| Domainex | View profile | 11-50 | Cambridge, Cambridgeshire, United Kingdom, Europe | http://www.domainex.co.uk |
| Syngene | View profile | 1001-5000 | Bangalore, Karnataka, India, Asia | http://www.syngeneintl.com |
| TCG Lifesciences | View profile | 501-1000 | Kolkata, West Bengal, India, Asia | http://www.tcgls.com/ |
| Dalton Pharma Services | View profile | 51-100 | Toronto, Ontario, Canada, North America | https://www.dalton.com/ |
| Pharmaceutical Product Development | View profile | 10001+ | Wilmington, North Carolina, United States, North America | https://ppd.com |
| Jubilant Biosys | View profile | 501-1000 | Bengaluru, Karnataka, India, Asia | https://www.jubilantbiosys.com/ |
| Pharmaron Beijing Co Ltd Ordinary Shares - Class H | View profile | 20295 | No. 248 Queen’s Road East, 40th Floor, Dah Sing Financial Centre, Wanchai, Hong Kong, Hong Kong | https://www.pharmaron.com |
| Evotec SE | View profile | 5055 | Essener Bogen 7, Manfred Eigen Campus, Hamburg, Germany, 22419 | https://www.evotec.com |
| Genscript Biotech Corp Class H | View profile | 6937 | No. 28, Yongxi Road, Jiangning Science Park, Jiangsu Province, Nanjing, China, People's Republic of, 211100 | https://www.genscript.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
| Eurofins Scientific SE | View profile | 61798 | 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 | https://www.eurofins.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
U.S. large molecule drug discovery outsourcing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to large molecule drug discovery outsourcing market will help companies and investors design strategic landscapes.
Lead identification & candidate optimization was the largest segment with a revenue share of 35.38% in 2024. Horizon Databook has segmented the U.S. large molecule drug discovery outsourcing market based on target identification & screening, target validation & functional informatics, lead identification & candidate optimization, preclinical development, other associated workflow covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to U.S. large molecule drug discovery outsourcing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. large molecule drug discovery outsourcing market databook
-
Our clientele includes a mix of large molecule drug discovery outsourcing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. large molecule drug discovery outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into U.S. large molecule drug discovery outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. large molecule drug discovery outsourcing market size, by workflow, 2018-2030 (US$M)
U.S. Large Molecule Drug Discovery Outsourcing Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
